Showing results (221-230 of 240) with videos related to
Sort By:
Pageof 24
Indian Journal of Cancer|June 16, 2026
District cancer control program: A white paper to optimize cancer care in rural India by developing a uniform, modular, and multi-tier systemNirav P Trivedi, T D Balamurugan, R Ravi Kannan, et al.American Journal of Physiology. Endocrinology and Metabolism|April 14, 2016
Linearity of β-cell response across the metabolic spectrum and to pharmacology: insights from a graded glucose infusion-based investigation seriesSudha S Shankar, R Ravi Shankar, Lori A Mixson, et al.Urology|March 19, 2004
Long-term follow-up of Anglian Germ Cell Cancer Group surveillance versus patients with Stage 1 nonseminoma treated with adjuvant chemotherapyR T D Oliver, J Ong, J Shamash, et al.Journal of Diabetes Investigation|May 17, 2016
Randomized clinical trial of the safety and efficacy of sitagliptin and metformin co-administered to Chinese patients with type 2 diabetes mellitusLinong Ji, Ping Han, Xiaoyue Wang, et al.Current Medical Research and Opinion|December 31, 2016
A randomized clinical trial of the safety and efficacy of sitagliptin in patients with type 2 diabetes mellitus inadequately controlled by acarbose aloneWeiqing Wang, Guang Ning, Jianhua Ma, et al.Chemosphere|November 27, 2021
Visible light photodegradation of 2,4-dichlorophenol using nanostructured NaBiS2: Kinetics, cytotoxicity, antimicrobial and electrochemical studies of the photocatalystV G Dileep Kumar, K R Balaji, R Viswanatha, et al.The British Journal of Radiology|April 4, 2014
Topical application of a sandal wood oil and turmeric based cream prevents radiodermatitis in head and neck cancer patients undergoing external beam radiotherapy: a pilot studyP L Palatty, A Azmidah, S Rao, et al.Nature Medicine|October 1, 1996
Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinaseS L Yao, A J Akhtar, K A McKenna, et al.Diabetes, Obesity & Metabolism|November 6, 2018
Double-blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase-4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT-I StudyRonan Roussel, Santiago Duran-García, Yilong Zhang, et al.The Journal of Clinical Endocrinology and Metabolism|March 11, 2022
Corifollitropin Alfa Combined With Human Chorionic Gonadotropin in Adolescent Boys With Hypogonadotropic HypogonadismR Ravi Shankar, Suneri Shah, Hee-Koung Joeng, et al.Pageof 24